VRDN Insider Trading

Insider Ownership Percentage: 1.43%
Insider Buying (Last 12 Months): $10,101,470.00
Insider Selling (Last 12 Months): $121,461.10

Viridian Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Viridian Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Viridian Therapeutics Share Price & Price History

Current Price: $17.51
Price Change: Price Increase of +0.14 (0.81%)
As of 03/27/2024 01:00 AM ET

This chart shows the closing price history over time for VRDN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Viridian Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/22/2024Fairmount Funds Management LlcDirectorBuy476,190$21.00$9,999,990.001,839,954View SEC Filing Icon  
6/15/2023Lara MeisnerInsiderSell2,269$28.02$63,577.3829,971View SEC Filing Icon  
6/5/2023Lara MeisnerInsiderSell499$25.03$12,489.9729,971View SEC Filing Icon  
6/2/2023Lara MeisnerInsiderSell1,875$24.21$45,393.7529,971View SEC Filing Icon  
4/12/2023Scott Dunseth MyersCEOBuy4,000$25.37$101,480.00259,500View SEC Filing Icon  
3/13/2023Scott Dunseth MyersCEOBuy5,500$29.15$160,325.00255,500View SEC Filing Icon  
3/9/2023Lara MeisnerGeneral CounselSell29,971$29.07$871,256.97View SEC Filing Icon  
2/2/2023Jonathan ViolinInsiderSell50,000$36.80$1,840,000.00430,905View SEC Filing Icon  
1/23/2023Lara MeisnerGeneral CounselSell6,843$35.66$244,021.38View SEC Filing Icon  
1/17/2023Barrett KatzinsiderSell24,853$37.21$924,780.13View SEC Filing Icon  
1/13/2023Barrett KatzinsiderSell4,147$37.01$153,480.47View SEC Filing Icon  
1/10/2023Barrett KatzinsiderSell47,377$35.30$1,672,408.10View SEC Filing Icon  
12/20/2022Lara MeisnerGeneral CounselSell600$28.07$16,842.00View SEC Filing Icon  
12/16/2022Lara MeisnerGeneral CounselSell1,297$28.44$36,886.68View SEC Filing Icon  
12/14/2022Lara MeisnerGeneral CounselSell15,656$28.12$440,246.72View SEC Filing Icon  
12/12/2022Lara MeisnerGeneral CounselSell600$28.05$16,830.00View SEC Filing Icon  
11/15/2022Lara MeisnerGeneral CounselSell8,125$22.05$179,156.25View SEC Filing Icon  
8/17/2022Fairmount Funds Management LlcDirectorBuy425,531$23.50$9,999,978.501,363,764View SEC Filing Icon  
6/1/2022Jonathan ViolinInsiderSell30,000$12.20$366,000.00480,905View SEC Filing Icon  
5/2/2022Jonathan ViolinCEOSell30,000$13.04$391,200.00510,905View SEC Filing Icon  
4/4/2022Jonathan ViolinInsiderSell3,600$18.93$68,148.00540,905View SEC Filing Icon  
4/1/2022Jonathan ViolinInsiderSell26,400$18.92$499,488.00540,905View SEC Filing Icon  
2/3/2022Jonathan ViolinInsiderSell909$19.16$17,416.44View SEC Filing Icon  
2/1/2022Jonathan ViolinInsiderSell16,751$19.55$327,482.05View SEC Filing Icon  
9/23/2021Life Sciences Public F FrazierMajor ShareholderBuy200,000$11.00$2,200,000.00View SEC Filing Icon  
9/21/2021Fairmount Funds Management LlcDirectorBuy909,000$11.00$9,999,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Viridian Therapeutics (NASDAQ:VRDN)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VRDN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Viridian Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.3,000,948$65.36M0.0%+22.6%4.781%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP192,097$4.18M0.0%-10.9%0.306%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.381,737$8.31M0.0%-4.4%0.608%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC19,456$0.42M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC1,730,212$37.68M0.8%+71.1%3.290%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD25,940$0.57M0.0%-2.2%0.049%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC4,787$0.10M0.1%+34.0%0.009%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc34,566$0.75M0.0%+26.3%0.066%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC219,593$4.78M0.0%+66.9%0.418%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.3,000,948$65.36M0.0%+22.6%5.707%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC125,000$2.72M0.1%-5.1%0.238%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC233,880$5.09M0.0%+15.0%0.445%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP620,000$13.50M2.2%-41.9%1.179%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD25,940$0.57M0.0%-2.2%0.049%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC32,991$0.72M0.0%-25.0%0.063%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada13,110$0.29M0.0%+123.4%0.025%Search for SEC Filing on Google Icon
2/14/2024Commodore Capital LP1,924,074$41.91M3.7%-12.5%3.659%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP323,102$7.04M0.3%-81.4%0.614%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG30,000$0.65M0.0%-53.0%0.057%Search for SEC Filing on Google Icon
2/14/2024Kynam Capital Management LP607,915$13.24M1.5%-13.1%1.156%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.41,214$0.90M0.0%+195.0%0.078%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP1,000,000$21.78M2.3%N/A1.902%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP605,816$13.20M0.2%N/A1.152%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp413,641$9.01M0.0%+3.0%0.787%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 2,331$51K0.0%-74.5%0.004%Search for SEC Filing on Google Icon
2/13/2024DCF Advisers LLC9,500$0.21M0.1%-29.6%0.018%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC50,000$1.09M0.2%N/A0.095%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.381,737$8.31M0.0%-4.4%0.726%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC202,491$4.41M0.0%-22.8%0.385%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System37,394$0.81M0.0%+3.9%0.071%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.453,308$9.87M0.1%-1.3%0.862%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG143,386$3.12M0.0%+109.6%0.273%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.10,875$0.24M0.0%-19.1%0.021%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.371,311$8.09M0.0%+18.5%0.706%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank67,200$1.46M0.0%+1.2%0.128%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.329,484$7.18M0.0%+10.1%0.627%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund17,495$0.38M0.0%+9.7%0.033%Search for SEC Filing on Google Icon
1/31/2024Knights of Columbus Asset Advisors LLC153,949$3.35M0.2%+420.9%0.293%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 8,369$0.18M0.0%+122.6%0.016%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.27,687$0.60M0.0%-5.3%0.053%Search for SEC Filing on Google Icon
1/24/2024Arizona State Retirement System9,533$0.21M0.0%N/A0.018%Search for SEC Filing on Google Icon
1/22/2024StoneCrest Wealth Management Inc.27,791$0.61M0.6%N/A0.053%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates10,228$0.22M0.0%-32.6%0.019%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC40,588$0.88M0.0%-60.5%0.077%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.2,448,015$37.55M0.0%-5.7%4.655%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.110,309$1.69M0.0%+38.3%0.210%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP215,648$3.31M0.0%+25.2%0.410%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG22,023$0.34M0.0%-76.2%0.042%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP10,844$0.17M0.0%N/A0.025%Search for SEC Filing on Google Icon
11/15/2023Kynam Capital Management LP699,681$10.73M1.8%-1.4%1.602%Search for SEC Filing on Google Icon
11/14/2023Braidwell LP1,735,182$26.62M0.8%+43.8%3.973%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC108,037$1.66M0.0%+362.3%0.247%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System35,996$0.55M0.0%-6.7%0.082%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 9,152$0.14M0.0%+84.8%0.021%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.80,002$1.23M0.0%-45.8%0.183%Search for SEC Filing on Google Icon
11/13/2023Eagle Asset Management Inc.459,169$7.04M0.0%+1.9%1.051%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp401,666$6.16M0.0%-1.0%0.920%Search for SEC Filing on Google Icon
11/13/2023Dark Forest Capital Management LP17,223$0.26M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC47,438$0.73M0.2%+5.4%0.109%Search for SEC Filing on Google Icon
11/13/2023Invesco Ltd.27,833$0.43M0.0%+43.2%0.064%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC262,296$4.02M0.0%+7.5%0.601%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers60,497$0.93M0.0%+1.7%0.139%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG22,023$0.34M0.0%-76.2%0.050%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.110,309$1.69M0.0%+38.3%0.253%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG68,416$1.05M0.0%-14.0%0.157%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.313,217$4.81M0.0%+170.5%0.717%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank66,400$1.02M0.0%+9.4%0.152%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC131,557$2.02M0.0%-48.9%0.301%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC61,654$0.95M0.0%+25.7%0.141%Search for SEC Filing on Google Icon
11/1/2023Knights of Columbus Asset Advisors LLC29,553$0.45M0.0%+2.9%0.068%Search for SEC Filing on Google Icon
10/27/2023Hennion & Walsh Asset Management Inc.27,112$0.42M0.0%+89.5%0.062%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.29,227$0.45M0.0%+17.8%0.067%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp138,177$2.12M0.0%-2.7%0.316%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates15,164$0.23M0.0%+71.1%0.035%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC102,667$1.58M0.0%+150.5%0.235%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC1,776,386$42.26M1.2%+2.3%4.068%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System38,569$0.92M0.0%-5.3%0.088%Search for SEC Filing on Google Icon
8/16/2023Nuveen Asset Management LLC426,195$10.14M0.0%-26.2%0.976%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.1,574,302$37.45M0.0%+26.5%3.605%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN68,887$1.64M0.0%+49.9%0.158%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP168,060$4M0.0%+40.7%0.385%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.315,557$7.51M0.0%-11.1%0.723%Search for SEC Filing on Google Icon
8/15/2023Royal Bank of Canada3,199$76K0.0%+48.8%0.007%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC45,000$1.07M0.3%+23.7%0.103%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC108,765$2.59M1.2%+14.6%0.249%Search for SEC Filing on Google Icon
8/15/2023Kopp Family Office LLC214,290$5.10M2.7%+63.2%0.491%Search for SEC Filing on Google Icon
8/15/2023Kynam Capital Management LP709,498$16.88M2.3%+30.5%1.625%Search for SEC Filing on Google Icon
8/15/2023Braidwell LP1,206,300$28.70M0.9%N/A2.762%Search for SEC Filing on Google Icon
8/15/2023Commodore Capital LP2,200,000$52.34M5.9%+0.5%5.038%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 4,953$0.12M0.0%+53.9%0.011%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC23,367$0.56M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP651,179$15.49M0.0%+3.5%1.491%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board30,223$0.72M0.0%-4.1%0.069%Search for SEC Filing on Google Icon
8/14/2023State Street Corp2,918,369$69.43M0.0%+21.5%6.683%Search for SEC Filing on Google Icon
8/14/2023Bellevue Group AG44,400$1.06M0.0%-3.7%0.102%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd100,000$2.38M0.0%N/A0.229%Search for SEC Filing on Google Icon
8/14/2023Deep Track Capital LP1,279,502$30.44M1.4%+4.0%2.930%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC426,195$10.14M0.0%-26.2%0.976%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC84,019$2M0.0%-79.3%0.192%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc1,600,000$38.06M0.3%+190.9%3.664%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Viridian Therapeutics logo
Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Read More on Viridian Therapeutics

Today's Range

Now: $17.51
Low: $17.14
High: $18.02

50 Day Range

MA: $18.74
Low: $17.09
High: $20.35

52 Week Range

Now: $17.51
Low: $10.93
High: $30.30

Volume

707,704 shs

Average Volume

1,170,223 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Viridian Therapeutics?

Viridian Therapeutics' top insider investors include:
  1. Fairmount Funds Management Llc (Director)
  2. Jonathan Violin (Insider)
  3. Jonathan Violin (CEO)
  4. Scott Dunseth Myers (CEO)
  5. Lara Meisner (Insider)
  6. Barrett Katz (Insider)
  7. Lara Meisner (General Counsel)
Learn More about top insider investors at Viridian Therapeutics.

Who are the major institutional investors of Viridian Therapeutics?

Viridian Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 5.71%
  2. Vanguard Group Inc. — 4.78%
  3. Commodore Capital LP — 3.66%
  4. Perceptive Advisors LLC — 3.29%
  5. Vestal Point Capital LP — 1.90%
  6. Octagon Capital Advisors LP — 1.18%
Learn More about top institutional investors of Viridian Therapeutics stock.

Which major investors are selling Viridian Therapeutics stock?

During the last quarter, VRDN stock was sold by these institutional investors:
  1. Braidwell LP
  2. Octagon Capital Advisors LP
  3. Commodore Capital LP
  4. Kynam Capital Management LP
  5. SG Americas Securities LLC
  6. Rafferty Asset Management LLC
  7. Bellevue Group AG
  8. Citadel Advisors LLC

Which major investors are buying Viridian Therapeutics stock?

Within the previous quarter, VRDN stock was acquired by institutional investors including:
  1. Vestal Point Capital LP
  2. Perceptive Advisors LLC
  3. RTW Investments LP
  4. Vanguard Group Inc.
  5. Vanguard Group Inc.
  6. Knights of Columbus Asset Advisors LLC
  7. Barclays PLC
  8. UBS Group AG
In the previous year, these company insiders have bought Viridian Therapeutics stock:
  1. Fairmount Funds Management Llc (Director)
  2. Jonathan Violin (Insider)
Learn More investors buying Viridian Therapeutics stock.